Oura just landed one of the year's biggest wearables funding rounds, raising over $900 million in Series E financing that values the Finnish smart ring maker at $11 billion. The massive round, led by Fidelity Management & Research Company with backing from ICONIQ, Whale Rock, and Atreides, comes as the company doubles revenue and prepares to hit $1 billion in annual sales.
Oura just pulled off one of the year's most significant wearables funding rounds, and the timing couldn't be more strategic. The Finnish company's $900 million Series E raise at an $11 billion valuation puts it in direct competition with tech giants like Apple and Samsung for the future of personal health monitoring.
The round, led by Fidelity Management & Research Company, signals serious institutional confidence in Oura's vision. New investor ICONIQ joined the round alongside Whale Rock and Atreides, bringing Oura's total funding to approximately $1.5 billion according to CNBC's reporting.
"With this investment, we will accelerate innovation, expand our global reach, and set a new standard for what wearables can achieve in advancing preventive health," CEO Tom Hale said in the announcement. The ambitious language reflects Oura's broader strategy to move beyond fitness tracking into comprehensive health management.
The numbers back up the hype. Oura has sold over 5.5 million rings since launching in 2015, with a dramatic acceleration from just 2.5 million units announced in June 2024. Revenue more than doubled to over $500 million in 2024, and the company expects to hit $1 billion in annual sales this year.
That growth trajectory puts Oura in rarified air among consumer hardware companies. The smart ring category, once a niche market, is suddenly attracting major players. Samsung launched its Galaxy Ring earlier this year, while companies like RingConn and established fitness brands like Whoop and Garmin are expanding their wearable offerings.
But Oura isn't just competing on hardware. The company's recent product launches reveal a broader ambition to become a comprehensive health platform. The new Oura Ring 4 Ceramic comes with Health Panels, a blood testing feature that lets users schedule lab work and view results directly in the Oura app. Users can track up to 50 biomarkers and receive personalized recommendations from Oura's AI-powered Advisor.
The AI integration represents a critical differentiator. While Watch focuses on fitness and basic health metrics, Oura is positioning itself as a proactive health management system. The company's , announced late last year, integrates continuous glucose monitoring with Oura's biometric data - a combination that could revolutionize diabetes management and metabolic health tracking.
